["{\n\"step_by_step_thinking\": \"The article 'Lung cancer: a review of current therapeutic modalities' mentions that the introduction of newer agents, such as CPT-11, has shown early favorable results. However, the impact of cisplatin-based regimens on overall survival in stage IV NSCLC remains disappointing. Additionally, the review 'Management of non-small cell and small cell lung cancer' states that chemotherapy is a major problem for selecting patients. Therefore, it seems that while some chemotherapies may have shown promise, the effectiveness of chemotherapy in advanced non-small cell lung carcinoma is still uncertain.\",\n\"answer_choice\": \"B\""]